Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Aarkstore enterprise---High-Growth Diagnostic Testing Markets

Posted Oct 27 2010 3:02am

Table of Contents :

1. Overview 7
1.1 Statement of Report 7
1.2 Objectives of this Report 7
1.3 Scope of this Report 8
1.4 Methodology 9
1.5 Executive Summary 9

2. Sector Overview 12
2.1 Global Diagnostic Products Industry 12

3. High-Growth Testing Markets: Market Segment Analysis: Size, Growth and Share 17
3.1 Global High-Growth Diagnostic Testing Markets 17
3.1.1 Market Drivers in the High-Growth Diagnostics Testing Sector - Overview 19
3.1.2 Market Segments for High-Growth Testing 19
3.1.3 Key Players in the High-Growth Diagnostics Testing Segment 20
3.1.4 High-Growth Testing Sector Analysis 21
3.2 U.S. High-Growth Testing Market 21
3.2.1 Market Overview 21
3.2.2 Diagnostic Test Categories 22
3.3 European High-Growth Diagnostic Test Market 22
3.3.1. German Diagnostic Markets 25
3.3.2 U.K. Testing Diagnostic Market 27
3.3.2.1 U.K. Market Statistics 28
3.3.2.2 U.K. Competitive Analysis 28
3.3.2.3 U.K. Market Access 29
3.4. Japanese Diagnostic Testing Market 30
3.5 Chinese Diagnostic Testing Market 30
3.6 High-Growth Testing Individual Markets 32
3.6.1 Hepatitis Serologic Markers and Nucleic Acid Testing 32
3.6.1.1 Hepatitis B Virus (HBV) 32
3.6.1.2 Hepatitis C Virus (HCV) Testing 42
3.6.1.3 Hepatitis B virus/Hepatitis C Virus Viral Load and Drug Resistance 49
3.6.2 Cardiac Markers 50
3.6.2.1 Market Overview 50
3.6.2.1.1 American Market 52
3.6.2.1.2 European Market 54
3.6.2.2 Acute Myocardial Infarction 55
3.6.2.3 Heart Failure (BNP) 56
3.6.2.3.1 Market Overview 56
3.6.2.3.2 Commercial Assays for BNP and NT-proBNP 57
3.6.2.3.3 Market Share 59
3.6.2.4 Myoglobin 62
3.6.2.5 Homocysteine 62
3.6.2.6 CRP 62
3.6.2.7 Pulmonary Embolism (D-Dimer Test) 63
3.6.2.8 LDL and HDL 63
3.6.2.9 Key Players 64
3.6.3 Cytogenetic Testing 71
3.6.3.1 Cancer Testing 71
3.6.3.2 Pre-natal Testing and Cytogenetics 73
3.6.3.2.1 Cystic Fibrosis Testing 74
3.6.3.3 Key Players in Segment 78
3.6.4 Fertility Testing 78
3.6.5 Clinical Laboratory Genomics 82
3.6.5.1 Introduction 82
3.6.5.2 Clinical Laboratory Genomics Testing 83
3.6.5.3 Developments in Clinical Laboratory Genomics 84
3.6.5.3.1 Nucleic Acid Amplification Techniques 84
3.6.5.3.2 Chromosome Imaging 84
3.6.5.3.3 Genomics Technologies 85
3.6.5.3.4 Proteomics Technology 85
3.6.5.3.5 Current Pharmacogenomic Tests 86
3.6.5.3.6 Future Pharmacogenomic Testing 87
3.6.6 Glycosylated Hemoglobin Glucose Monitoring 88
3.6.6.1 Overview of Market Segment 92
3.6.6.2 Competitive Strategies 93
3.6.6.3 Analyses of the Current Market Conditions, Competition and Product Mix 93
3.6.6.3.1 First-Generation Monitors 93
3.6.6.3.2 Second-Generation Monitors 94
3.6.6.3.3 Third-Generation SMBG Technologies 95
3.6.6.3.4 Other Monitoring Device Advancements 96
3.6.7 Cancer BioMarker Testing 96
3.6.7.1 Segment Overview 96
3.6.7.2 The Cancer Testing Market 98
3.6.7.3 Competition 99
3.6.7.4 Individual Markets 100
3.6.7.4.1 Cancer Pathology: Testing 100
3.6.7.4.1.1 Rare Cell/Micro Metastasis Detection 100
3.6.7.4.1.2 Cancer Pathology: High Throughput Screening 101
3.6.7.4.1.3 Competition 102


For more information please contact :

http://www.aarkstore.com/reports/High-Growth-Diagnostic-Testing-Markets-1316.htm

http://blogs.aarkstore.com/

From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com

Post a comment
Write a comment: